F-Star Therapeutics Inc
(FSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,488 | -31,081 | -12,087 | -31,283 | -36,024 |
| Depreciation Amortization | 669 | 427 | 229 | 734 | 569 |
| Accounts payable and accrued liabilities | -125 | 1,223 | 1,197 | -1,499 | -3,050 |
| Other Working Capital | -8,346 | -3,214 | -2,135 | -7,129 | -5,890 |
| Other Operating Activity | 12,595 | 4,498 | 1,181 | 11,910 | 10,347 |
| Operating Cash Flow | $-44,695 | $-28,147 | $-11,615 | $-27,267 | $-34,048 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -244 | -235 | N/A | -643 | -643 |
| Purchase Sale Intangibles | -111 | -121 | N/A | N/A | 0 |
| Other Investing Activity | -111 | -121 | 0 | 0 | 0 |
| Investing Cash Flow | $-355 | $-356 | $N/A | $-643 | $-643 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 9,845 | 9,753 |
| Common Stock Issued | 2,310 | 2,269 | 1,949 | 78,346 | 77,295 |
| Other Financing Activity | -123 | -87 | -70 | -92 | 0 |
| Financing Cash Flow | $2,187 | $2,182 | $1,879 | $88,099 | $87,048 |
| Exchange Rate Effect | -118 | 735 | -12 | -166 | 167 |
| Beginning Cash Position | 78,549 | 78,549 | 78,549 | 18,526 | 18,526 |
| End Cash Position | 35,568 | 52,963 | 68,801 | 78,549 | 71,050 |
| Net Cash Flow | $-42,981 | $-25,586 | $-9,748 | $60,023 | $52,524 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,695 | -28,147 | -11,615 | -27,267 | -34,048 |
| Capital Expenditure | -282 | -235 | N/A | -658 | -658 |
| Free Cash Flow | -44,977 | -28,382 | -11,615 | -27,925 | -34,706 |